Your views
Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 19 November 2024
Time: 22:28
Patients discharged on appropriate drugs: ACE inhibitors and ARBs
How is the Trust doing?
| Rolling year to date (February 2019 – January 2020) | 89.1% |
|---|---|
| Rolling 2 years (February 2018 – January 2020) | 82.1% |
Performance remains stable but the Trust is aiming for 93% of heart failure patients to be discharged on angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs).
Why is this indicator important?
Angiotensin-converting enzyme (ACE) inhibitors have been shown to improve survival in patients with heart failure. Angiotensin receptor blockers (ARBs) have a similar effect to ACE inhibitors and can be used as an alternative for patients who cannot tolerate ACE inhibitors. ACE inhibitors and ARBs are sometimes used in combination.
How do we measure this indicator?
Emergency admission patients with a primary diagnosis of heart failure on discharge are extracted from Lorenzo. The Prescribing Information and Communication System (PICS) is then checked to see if the patient was prescribed ACE inhibitors or ARBs to take home. As patients are usually started on a low dose of an ACE inhibitor or ARB which is then slowly increased over a number of weeks, any dose is included in the indicator.
Data sources
- Oceano: patient administration system
- PICS: Prescribing Information and Communication System
Related pages
Getting here
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn why.
